{
  "name": "Active Biotech",
  "slug": "active-biotech",
  "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.",
  "status": "complete",
  "updated_at": "2026-08-07T00:49:27Z",
  "nasdaq_status": "retrieved",
  "latest_market": "2026-08-06: stängning 5.35, volym 67100",
  "mfn_status": "resolved_no_reports",
  "mfn_count": 0,
  "nasdaq_reports_status": "retrieved",
  "reports": {
    "available": true,
    "url": "/company/active-biotech/reports",
    "count": 16,
    "nasdaq_count": 16,
    "mfn_fallback_count": 0,
    "items": [
      {
        "report_key": "2026:q1",
        "period_label": "2026 Q1",
        "date": "2026-05-07",
        "title": "Kvartalsrapport Q1 2026",
        "original_title": "Active Biotech Delårsrapport Q1 2026",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bee48b273a4f615b8fb942a861d58aa1a&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
            "title": "Kvartalsrapport Q1 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aa9154e51b3d97e5e453283ca69f7982a",
            "date": "2026-05-07",
            "period": "2026-q1",
            "form_type": "interim-report",
            "report_key": "2026:q1",
            "filename": "Active_Biotech_Rapport_2026_Q1_Sve.pdf",
            "text_chars": 49140,
            "sha256": "e250c958f1f47dd069c5af84cd6f79ff434a8dd18adfbe6d65b227a9ad69c337",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
                "chars": 49140
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:annual",
        "period_label": "2025 Årsredovisning",
        "date": "2026-04-01",
        "title": "Årsredovisning 2025",
        "original_title": "Årsredovisning 2025 Active Biotech AB (publ)",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bc60641b2a257ed8ab19c1b17b5ec5efc&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2025,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2025",
            "title": "Årsredovisning 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a021c93eb2bff7249e5f5fdf0518a9c4b",
            "date": "2026-04-01",
            "period": "2025-annual",
            "form_type": "annual-report",
            "report_key": "2025:annual",
            "filename": "Active_Biotech_2025_Sve.pdf",
            "text_chars": 283895,
            "sha256": "88bf9db8a8abec5d77d1333dc40e9fc0c94fa3a357c6501b67d9985bc8247a9b",
            "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
                "chars": 179320
              },
              {
                "number": 2,
                "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
                "chars": 104573
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q4",
        "period_label": "2025 Q4",
        "date": "2026-02-12",
        "title": "Kvartalsrapport Q4 2025",
        "original_title": "Active Biotech Bokslutsrapport 2025",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b05fe5be301b2d2469e148da1273a9c7b&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2025,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
            "title": "Kvartalsrapport Q4 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aca159b19464ce4a453db1195556593e8",
            "date": "2026-02-12",
            "period": "2025-q4",
            "form_type": "year-end-report",
            "report_key": "2025:q4",
            "filename": "Active_Biotech_Rapport_2025_Q4_Sve.pdf",
            "text_chars": 54948,
            "sha256": "51d53e436a17b0f7117d184eeec2af8688c0ff7fe40da65c08c7e7435c05d449",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
                "chars": 54948
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q3",
        "period_label": "2025 Q3",
        "date": "2025-11-06",
        "title": "Kvartalsrapport Q3 2025",
        "original_title": "Active Biotech delårsrapport Q3 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b5322e87a44419553cc1746c567ae2fd0&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
            "title": "Kvartalsrapport Q3 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a72cf8adad377196c5f57d9153e93fe7b",
            "date": "2025-11-06",
            "period": "2025-q3",
            "form_type": "interim-report",
            "report_key": "2025:q3",
            "filename": "Active_Biotech_Rapport_2025_Q3_Sve.pdf",
            "text_chars": 62633,
            "sha256": "d1480f822f3ddd272476ed46d0c6a45cb5ba32c625da8685b3ca91513738d4a4",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
                "chars": 62633
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q2",
        "period_label": "2025 Q2",
        "date": "2025-08-21",
        "title": "Kvartalsrapport Q2 2025",
        "original_title": "DELÅRSRAPPORT Q2 2025",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b7e1ca8a151719b1e37058ff128147e77&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
            "title": "Kvartalsrapport Q2 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a2eccc638698c9f2aea2022c142042bb7",
            "date": "2025-08-21",
            "period": "2025-q2",
            "form_type": "interim-report",
            "report_key": "2025:q2",
            "filename": "Active_Biotech_Rapport_2025_Q2_Sve.pdf",
            "text_chars": 58751,
            "sha256": "85660e7863f0fe0d042a855e88c9e3f23ad15b38847790e7a9faeee8a7ee3425",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
                "chars": 58751
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q1",
        "period_label": "2025 Q1",
        "date": "2025-05-08",
        "title": "Kvartalsrapport Q1 2025",
        "original_title": "Active Biotech delårsrapport Q1 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b055430f65efaa49c622e229c9385e108&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
            "title": "Kvartalsrapport Q1 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aecd93218278374230f26f6f12d3c90ea",
            "date": "2025-05-08",
            "period": "2025-q1",
            "form_type": "interim-report",
            "report_key": "2025:q1",
            "filename": "Active_Biotech_Rapport_2025_Q1_Sve.pdf",
            "text_chars": 57126,
            "sha256": "2a217ea547a4d70cd9d87ff1aa88f1542037927c5188e4337bea8524a4c46526",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
                "chars": 57126
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:annual",
        "period_label": "2024 Årsredovisning",
        "date": "2025-04-07",
        "title": "Årsredovisning 2024",
        "original_title": "Årsredovisning 2024 Active Biotech AB (publ)",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b724053a13819d17ec1c9048701f12842&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2024,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2024",
            "title": "Årsredovisning 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ab29fe1da63c9680f3d6aad7159c9a6da",
            "date": "2025-04-07",
            "period": "2024-annual",
            "form_type": "annual-report",
            "report_key": "2024:annual",
            "filename": "Active_Biotech_2024_Sve.pdf",
            "text_chars": 307165,
            "sha256": "97a68ebdc4b298c49c560a2d6c993da29fdb93c16e92d9b0b3b6789ccc1e917e",
            "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
                "chars": 179118
              },
              {
                "number": 2,
                "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
                "chars": 128045
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q4",
        "period_label": "2024 Q4",
        "date": "2025-02-13",
        "title": "Kvartalsrapport Q4 2024",
        "original_title": "Active Biotech Bokslutsrapport 2024",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=ba5d12534fe6e12b43c25214f5fba7086&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2024,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
            "title": "Kvartalsrapport Q4 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a3ec16aacb121a02bfd3f46ba313c9765",
            "date": "2025-02-13",
            "period": "2024-q4",
            "form_type": "year-end-report",
            "report_key": "2024:q4",
            "filename": "Active_Biotech_Rapport_2024_Q4_Sve.pdf",
            "text_chars": 62464,
            "sha256": "1d489c064de78126550f227dfaa46219d75dcc06c14bea92c16e7282d4d53600",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
                "chars": 62464
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q3",
        "period_label": "2024 Q3",
        "date": "2024-10-21",
        "title": "Kvartalsrapport Q3 2024",
        "original_title": "Active Biotech Delårsrapport Q3 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bd007a591d56967abc41a0e1a5dbafd77&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
            "title": "Kvartalsrapport Q3 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a4bc6d31be9beb9745e1e34b0e4a1edc4",
            "date": "2024-10-21",
            "period": "2024-q3",
            "form_type": "interim-report",
            "report_key": "2024:q3",
            "filename": "AB_Rapport_2024_Q3_Sv.pdf",
            "text_chars": 63888,
            "sha256": "77a80580a0321f6c96d9a9f0e4c774c403e922a97bb83990046a2a7ec0f28e58",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
                "chars": 63888
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q2",
        "period_label": "2024 Q2",
        "date": "2024-08-22",
        "title": "Kvartalsrapport Q2 2024",
        "original_title": "Active Biotech delårsrapport Q2 2024",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b3fe2cf10af9bff7a22824dc89c4c966c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
            "title": "Kvartalsrapport Q2 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ac3cca813fd679370e9c4112973da021a",
            "date": "2024-08-22",
            "period": "2024-q2",
            "form_type": "interim-report",
            "report_key": "2024:q2",
            "filename": "AB_Rapport_2024_Q2_Sv.pdf",
            "text_chars": 55542,
            "sha256": "f362dcc495266d00e8080a3417b90aacf73918d44a5706df3b43740adc2c07da",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
                "chars": 55542
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q1",
        "period_label": "2024 Q1",
        "date": "2024-05-08",
        "title": "Kvartalsrapport Q1 2024",
        "original_title": "Active Biotech delårsrapport Q1 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b95302693ae6c1569f65cf4eb490aeb94&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
            "title": "Kvartalsrapport Q1 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a17370e61d30ce886f91e99fb458bf4a7",
            "date": "2024-05-08",
            "period": "2024-q1",
            "form_type": "interim-report",
            "report_key": "2024:q1",
            "filename": "AB_Rapport_2024_Q1_Sv.pdf",
            "text_chars": 59047,
            "sha256": "84816ad79acd600c1002df056671c601cd5f3a9014bfa8a375e6691dfc05cd20",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
                "chars": 59047
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:annual",
        "period_label": "2023 Årsredovisning",
        "date": "2024-04-22",
        "title": "Årsredovisning 2023",
        "original_title": "Årsredovisning 2023 Active Biotech AB (publ)",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bb8e999164dd059108f90c64638ef95a3&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2023,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2023",
            "title": "Årsredovisning 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ae773646c51c9e2f2a2f1168fc7e5e9ac",
            "date": "2024-04-22",
            "period": "2023-annual",
            "form_type": "annual-report",
            "report_key": "2023:annual",
            "filename": "Active_Biotech_2023_Sve.pdf",
            "text_chars": 309681,
            "sha256": "dc8762605d28fa90683f0dd2f7360f7014cb8a2b80a66c487a1e0c0e45bfe00b",
            "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
                "chars": 179795
              },
              {
                "number": 2,
                "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
                "chars": 129884
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q4",
        "period_label": "2023 Q4",
        "date": "2024-02-08",
        "title": "Kvartalsrapport Q4 2023",
        "original_title": "Active Biotech Bokslutsrapport 2023",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b604c9fbb9e1d09c0c4de418aee6a072c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2023,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
            "title": "Kvartalsrapport Q4 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a8f42024facc84fdf446634de9530a785",
            "date": "2024-02-08",
            "period": "2023-q4",
            "form_type": "year-end-report",
            "report_key": "2023:q4",
            "filename": "Ab_Rapport_2023_Q4_Sve.pdf",
            "text_chars": 60458,
            "sha256": "ebce3b66d7388f46aa065db4f459da99c780abd5e9e1d65e7b797b6e9110c902",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
                "chars": 60458
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q3",
        "period_label": "2023 Q3",
        "date": "2023-11-09",
        "title": "Kvartalsrapport Q3 2023",
        "original_title": "Active Biotech Delårsrapport Q3 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=ba27eb7833d20e502021a62a0e3c7871a&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
            "title": "Kvartalsrapport Q3 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/acb03ff15ede6f7e732c107c1215c31a2",
            "date": "2023-11-09",
            "period": "2023-q3",
            "form_type": "interim-report",
            "report_key": "2023:q3",
            "filename": "AB_Rapport_2023_Q3_Sve.pdf",
            "text_chars": 57125,
            "sha256": "0ab6e23509f4801ef2e4592682fcfbdde699b9c747c21cb5f55148a17450a0b4",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
                "chars": 57125
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q2",
        "period_label": "2023 Q2",
        "date": "2023-08-24",
        "title": "Kvartalsrapport Q2 2023",
        "original_title": "Active Biotech Delårsrapport Q2 2023",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b51bf50e9e3c53c4feff148794f44717d&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
            "title": "Kvartalsrapport Q2 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a7c98e6507d7d6797788f40ef09b5d08c",
            "date": "2023-08-24",
            "period": "2023-q2",
            "form_type": "interim-report",
            "report_key": "2023:q2",
            "filename": "AB_Rapport_2023_Q2_Sve.pdf",
            "text_chars": 54776,
            "sha256": "c636f03354ee1882c569d5de9cded35144067806557ae0a625d1ba32984715d8",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
                "chars": 54776
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q1",
        "period_label": "2023 Q1",
        "date": "2023-05-04",
        "title": "Kvartalsrapport Q1 2023",
        "original_title": "Active Biotech Delårsrapport Q1 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b41ea85cce40bfd5a91f91d5edf20a595&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
            "title": "Kvartalsrapport Q1 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad79d1d4f816db9df4983e5c20a487f00",
            "date": "2023-05-04",
            "period": "2023-q1",
            "form_type": "interim-report",
            "report_key": "2023:q1",
            "filename": "Ab_Rapport_2023_Q1_Sv.pdf",
            "text_chars": 49168,
            "sha256": "1df5459e6d41478ac51332604cb705bb83ffdeba18557359b0ecd6e222cccb10",
            "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
                "chars": 49168
              }
            ]
          }
        ],
        "alternatives": []
      }
    ]
  },
  "report_count": 16,
  "nasdaq_report_count": 16,
  "mfn_fallback_count": 0,
  "sec_status": "skipped",
  "sec_count": 0,
  "fi_status": "retrieved",
  "fi_summary": {
    "company": "Active Biotech",
    "identity": {
      "issuer": "Active Biotech AB (publ)",
      "lei": "549300OJ44CLMRU8YE43",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 15,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "Active Biotech",
      "query": "Active Biotech AB (publ)",
      "candidate_count": 345
    },
    "period": {
      "from": "2024-08-07",
      "to": "2026-08-07",
      "years": 2
    },
    "generated_at": "2026-08-07T00:49:26Z",
    "insider": {
      "transactions": 14,
      "all_export_rows": 14,
      "acquisitions": 3,
      "disposals": 1,
      "other": 10,
      "acquisition_value_sek": 1530788.9,
      "disposal_value_sek": 3603.68,
      "characters": {
        "Avyttring": 1,
        "Förvärv": 3,
        "Teckning": 6,
        "Tilldelning": 4
      }
    },
    "short_selling": {
      "aggregate_percent": 0.19,
      "current_public_positions": 0,
      "historical_changes": 17,
      "current_position_sum_over_0_5": 0
    },
    "sources": {
      "insider_register": "https://www.fi.se/sv/vara-register/insynsregistret/",
      "short_register": "https://www.fi.se/sv/vara-register/blankningsregistret/"
    }
  },
  "warnings": [
    "MFN fallback: resolved_no_reports"
  ],
  "source_identity": {
    "nasdaq_reports": {
      "slug": "",
      "instrument_id": "TX139",
      "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/acti?id=TX139"
    },
    "mfn": {
      "status": "resolved",
      "company_name": "Active Biotech",
      "expected_name": "Active Biotech",
      "match_score": 100.0,
      "slug": "active-biotech",
      "url": "https://mfn.se/all/a/active-biotech",
      "metadata": {
        "country": "Sverige",
        "list": "Small Cap Stockholm",
        "sector": "Hälsovård",
        "industry": "Bioteknik",
        "website": "https://career.modularfinance.se"
      },
      "ticker_candidates": [],
      "attempts": []
    },
    "sec": null,
    "nasdaq": {
      "instrument_id": "TX139",
      "asset_class": "SHARES",
      "isin": "SE0029278555",
      "symbol": "ACTI",
      "company": "Active Biotech",
      "market": null,
      "last_sale_price": "SEK 5.35",
      "time_as_of": "2026-08-06"
    },
    "finansinspektionen": {
      "issuer": "Active Biotech AB (publ)",
      "lei": "549300OJ44CLMRU8YE43",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 15,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "Active Biotech",
      "query": "Active Biotech AB (publ)",
      "candidate_count": 345
    }
  },
  "documents": [
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
      "title": "Kvartalsrapport Q1 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aa9154e51b3d97e5e453283ca69f7982a",
      "date": "2026-05-07",
      "period": "2026-q1",
      "form_type": "interim-report",
      "report_key": "2026:q1",
      "filename": "Active_Biotech_Rapport_2026_Q1_Sve.pdf",
      "text_chars": 49140,
      "sha256": "e250c958f1f47dd069c5af84cd6f79ff434a8dd18adfbe6d65b227a9ad69c337",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
          "chars": 49140
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2025",
      "title": "Årsredovisning 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a021c93eb2bff7249e5f5fdf0518a9c4b",
      "date": "2026-04-01",
      "period": "2025-annual",
      "form_type": "annual-report",
      "report_key": "2025:annual",
      "filename": "Active_Biotech_2025_Sve.pdf",
      "text_chars": 283895,
      "sha256": "88bf9db8a8abec5d77d1333dc40e9fc0c94fa3a357c6501b67d9985bc8247a9b",
      "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
          "chars": 179320
        },
        {
          "number": 2,
          "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
          "chars": 104573
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
      "title": "Kvartalsrapport Q4 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aca159b19464ce4a453db1195556593e8",
      "date": "2026-02-12",
      "period": "2025-q4",
      "form_type": "year-end-report",
      "report_key": "2025:q4",
      "filename": "Active_Biotech_Rapport_2025_Q4_Sve.pdf",
      "text_chars": 54948,
      "sha256": "51d53e436a17b0f7117d184eeec2af8688c0ff7fe40da65c08c7e7435c05d449",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
          "chars": 54948
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
      "title": "Kvartalsrapport Q3 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a72cf8adad377196c5f57d9153e93fe7b",
      "date": "2025-11-06",
      "period": "2025-q3",
      "form_type": "interim-report",
      "report_key": "2025:q3",
      "filename": "Active_Biotech_Rapport_2025_Q3_Sve.pdf",
      "text_chars": 62633,
      "sha256": "d1480f822f3ddd272476ed46d0c6a45cb5ba32c625da8685b3ca91513738d4a4",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
          "chars": 62633
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
      "title": "Kvartalsrapport Q2 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a2eccc638698c9f2aea2022c142042bb7",
      "date": "2025-08-21",
      "period": "2025-q2",
      "form_type": "interim-report",
      "report_key": "2025:q2",
      "filename": "Active_Biotech_Rapport_2025_Q2_Sve.pdf",
      "text_chars": 58751,
      "sha256": "85660e7863f0fe0d042a855e88c9e3f23ad15b38847790e7a9faeee8a7ee3425",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
          "chars": 58751
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
      "title": "Kvartalsrapport Q1 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aecd93218278374230f26f6f12d3c90ea",
      "date": "2025-05-08",
      "period": "2025-q1",
      "form_type": "interim-report",
      "report_key": "2025:q1",
      "filename": "Active_Biotech_Rapport_2025_Q1_Sve.pdf",
      "text_chars": 57126,
      "sha256": "2a217ea547a4d70cd9d87ff1aa88f1542037927c5188e4337bea8524a4c46526",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
          "chars": 57126
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2024",
      "title": "Årsredovisning 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ab29fe1da63c9680f3d6aad7159c9a6da",
      "date": "2025-04-07",
      "period": "2024-annual",
      "form_type": "annual-report",
      "report_key": "2024:annual",
      "filename": "Active_Biotech_2024_Sve.pdf",
      "text_chars": 307165,
      "sha256": "97a68ebdc4b298c49c560a2d6c993da29fdb93c16e92d9b0b3b6789ccc1e917e",
      "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
          "chars": 179118
        },
        {
          "number": 2,
          "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
          "chars": 128045
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
      "title": "Kvartalsrapport Q4 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a3ec16aacb121a02bfd3f46ba313c9765",
      "date": "2025-02-13",
      "period": "2024-q4",
      "form_type": "year-end-report",
      "report_key": "2024:q4",
      "filename": "Active_Biotech_Rapport_2024_Q4_Sve.pdf",
      "text_chars": 62464,
      "sha256": "1d489c064de78126550f227dfaa46219d75dcc06c14bea92c16e7282d4d53600",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
          "chars": 62464
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
      "title": "Kvartalsrapport Q3 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a4bc6d31be9beb9745e1e34b0e4a1edc4",
      "date": "2024-10-21",
      "period": "2024-q3",
      "form_type": "interim-report",
      "report_key": "2024:q3",
      "filename": "AB_Rapport_2024_Q3_Sv.pdf",
      "text_chars": 63888,
      "sha256": "77a80580a0321f6c96d9a9f0e4c774c403e922a97bb83990046a2a7ec0f28e58",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
          "chars": 63888
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
      "title": "Kvartalsrapport Q2 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ac3cca813fd679370e9c4112973da021a",
      "date": "2024-08-22",
      "period": "2024-q2",
      "form_type": "interim-report",
      "report_key": "2024:q2",
      "filename": "AB_Rapport_2024_Q2_Sv.pdf",
      "text_chars": 55542,
      "sha256": "f362dcc495266d00e8080a3417b90aacf73918d44a5706df3b43740adc2c07da",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
          "chars": 55542
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
      "title": "Kvartalsrapport Q1 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a17370e61d30ce886f91e99fb458bf4a7",
      "date": "2024-05-08",
      "period": "2024-q1",
      "form_type": "interim-report",
      "report_key": "2024:q1",
      "filename": "AB_Rapport_2024_Q1_Sv.pdf",
      "text_chars": 59047,
      "sha256": "84816ad79acd600c1002df056671c601cd5f3a9014bfa8a375e6691dfc05cd20",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
          "chars": 59047
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2023",
      "title": "Årsredovisning 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ae773646c51c9e2f2a2f1168fc7e5e9ac",
      "date": "2024-04-22",
      "period": "2023-annual",
      "form_type": "annual-report",
      "report_key": "2023:annual",
      "filename": "Active_Biotech_2023_Sve.pdf",
      "text_chars": 309681,
      "sha256": "dc8762605d28fa90683f0dd2f7360f7014cb8a2b80a66c487a1e0c0e45bfe00b",
      "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
          "chars": 179795
        },
        {
          "number": 2,
          "url": "/company/active-biotech/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
          "chars": 129884
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
      "title": "Kvartalsrapport Q4 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a8f42024facc84fdf446634de9530a785",
      "date": "2024-02-08",
      "period": "2023-q4",
      "form_type": "year-end-report",
      "report_key": "2023:q4",
      "filename": "Ab_Rapport_2023_Q4_Sve.pdf",
      "text_chars": 60458,
      "sha256": "ebce3b66d7388f46aa065db4f459da99c780abd5e9e1d65e7b797b6e9110c902",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
          "chars": 60458
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
      "title": "Kvartalsrapport Q3 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/acb03ff15ede6f7e732c107c1215c31a2",
      "date": "2023-11-09",
      "period": "2023-q3",
      "form_type": "interim-report",
      "report_key": "2023:q3",
      "filename": "AB_Rapport_2023_Q3_Sve.pdf",
      "text_chars": 57125,
      "sha256": "0ab6e23509f4801ef2e4592682fcfbdde699b9c747c21cb5f55148a17450a0b4",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
          "chars": 57125
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
      "title": "Kvartalsrapport Q2 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a7c98e6507d7d6797788f40ef09b5d08c",
      "date": "2023-08-24",
      "period": "2023-q2",
      "form_type": "interim-report",
      "report_key": "2023:q2",
      "filename": "AB_Rapport_2023_Q2_Sve.pdf",
      "text_chars": 54776,
      "sha256": "c636f03354ee1882c569d5de9cded35144067806557ae0a625d1ba32984715d8",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
          "chars": 54776
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
      "title": "Kvartalsrapport Q1 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad79d1d4f816db9df4983e5c20a487f00",
      "date": "2023-05-04",
      "period": "2023-q1",
      "form_type": "interim-report",
      "report_key": "2023:q1",
      "filename": "Ab_Rapport_2023_Q1_Sv.pdf",
      "text_chars": 49168,
      "sha256": "1df5459e6d41478ac51332604cb705bb83ffdeba18557359b0ecd6e222cccb10",
      "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "txt_url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
          "chars": 49168
        }
      ]
    },
    {
      "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
      "title": "MFN bolagssida och bolagsmetadata",
      "source": "MFN",
      "source_class": "mfn",
      "source_url": "https://mfn.se/all/a/active-biotech",
      "date": null,
      "period": null,
      "form_type": "company-page",
      "report_key": null,
      "filename": "company.txt",
      "text_chars": 14197,
      "sha256": "7a26fad74b31f89ddd6760f51f1da93a73b1d400b1d7705db0224c260a50df7a",
      "url": "/company/active-biotech/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "absolute_url": "https://spela.port0.org/company/active-biotech/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "txt_url": "/company/active-biotech/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/active-biotech/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/active-biotech/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
          "chars": 14197
        }
      ]
    }
  ],
  "market_files": [
    {
      "label": "Nasdaq kurshistorik CSV",
      "url": "/company/active-biotech/market/history.csv",
      "absolute_url": "https://spela.port0.org/company/active-biotech/market/history.csv"
    },
    {
      "label": "Nasdaq kurshistorik JSON",
      "url": "/company/active-biotech/market/history.json",
      "absolute_url": "https://spela.port0.org/company/active-biotech/market/history.json"
    },
    {
      "label": "Nasdaq manifest JSON",
      "url": "/company/active-biotech/market/manifest.json",
      "absolute_url": "https://spela.port0.org/company/active-biotech/market/manifest.json"
    },
    {
      "label": "Nasdaq instrumentidentitet JSON",
      "url": "/company/active-biotech/market/instrument.json",
      "absolute_url": "https://spela.port0.org/company/active-biotech/market/instrument.json"
    },
    {
      "label": "MFN manifest JSON",
      "url": "/company/active-biotech/market/mfn-manifest.json",
      "absolute_url": "https://spela.port0.org/company/active-biotech/market/mfn-manifest.json"
    },
    {
      "label": "Nasdaq rapportmanifest JSON",
      "url": "/company/active-biotech/market/nasdaq-reports-manifest.json",
      "absolute_url": "https://spela.port0.org/company/active-biotech/market/nasdaq-reports-manifest.json"
    }
  ],
  "sec_facts": {
    "status": "missing",
    "metrics": []
  },
  "morningstar": {
    "configured": false,
    "status": "inte hämtad",
    "captured_at": null,
    "view_count": 0,
    "url": "/company/active-biotech/morningstar"
  },
  "finansinspektionen": {
    "available": true,
    "status": "retrieved",
    "url": "/company/active-biotech/finansinspektionen",
    "transaction_count": 14,
    "aggregate_short_percent": 0.19,
    "files": [
      {
        "filename": "summary.json",
        "label": "Sammanfattning JSON",
        "url": "summary.json"
      },
      {
        "filename": "insider-transactions.csv",
        "label": "Insynstransaktioner CSV",
        "url": "insider-transactions.csv"
      },
      {
        "filename": "insider-transactions.json",
        "label": "Insynstransaktioner JSON",
        "url": "insider-transactions.json"
      },
      {
        "filename": "short-current.json",
        "label": "Aktuella blankningspositioner JSON",
        "url": "short-current.json"
      },
      {
        "filename": "short-history.json",
        "label": "Historiska blankningspositioner JSON",
        "url": "short-history.json"
      },
      {
        "filename": "short-aggregate.json",
        "label": "Aggregerad blankning JSON",
        "url": "short-aggregate.json"
      },
      {
        "filename": "manifest.json",
        "label": "Hämtningsmanifest JSON",
        "url": "manifest.json"
      }
    ]
  },
  "llms_url": "/company/active-biotech/llms.txt",
  "json_url": "/company/active-biotech/company.json",
  "document_index_url": "/company/active-biotech/documents.json",
  "absolute_url": "https://spela.port0.org/company/active-biotech"
}